CVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance and expects to raise insurance plan prices in the coming year as it adjusts for Medicare ...
Hosted on MSN
CVS Health (NYSE:CVS) Delivers Strong Q3 Numbers
Diversified healthcare company CVS Health (NYSE:CVS) reported in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results